Products - Skin infections | Topic | NICE

Showing 3 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Nemolizumab for treating prurigo nodularis [ID6451]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
10 June 2026
Povorcitinib for treating moderate to severe active hidradenitis suppurativa after a TNF-alpha inhibitor [ID6569]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ruxolitinib for Prurigo Nodularis [ID6571]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC